title: Muramyl dipeptide (MDP) and 5-HT receptors. Neuroimmunomodulatory effects of MDP are probably not mediated through 5-HT4 or 5-HT1A receptors.
abstract: A possible interaction of immunomodulator muramyl dipeptide (MDP) with 5-HT4 and 5-HT1A receptors was investigated. The activation of 5-HT4 receptors releases acetylcholine from nerve terminals, thereby contracting the guinea-pig distal ileum. The whole ileum segments were therefore cut and placed into the bath. The preparations were contracted by 5-HT (10 nM-3.2 microM); these contractions were totally abolished in the presence of atropine (1 microM) and significantly attenuated in the presence of SDZ-205,557 (320 nM). The 5-HT evoked contractions remained unchanged in the presence of MDP (5, 50 or 500 nM). MDP (l0 nM-3.2 microM) could not directly contract the preparations. In further experiments, the possible interaction of MDP with 5-HT1A receptors was investigated. The activation of 5-HT1A receptors inhibits the release of acetylcholine from nerve terminals, thereby decreasing the height of electrically evoked neurogenic twitches of guinea-pig ileum. The whole ileum segments were cut, placed into the bath and stimulated electrically. Selective 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) decreased the height of twitches and this effect was significantly attenuated in the presence of 5-HT antagonist metergoline (1 microM). The effect of 8-OH-DPAT remained unchanged in the presence of MDP (5, 50 or 500 nM). MDP (10 nM-3.2 microM) did not exert any direct effect on the preparations. These results suggest that MDP interacts with neither 5-HT4 nor 5-HT1A receptors.
authors.affiliation: Institute of Pharmacology, Academy of Sciences of the Czech Republic, Prague. sevcik@biomed.cas.cz
authors.forename: Jan
authors.initials: J
authors.lastname: Sevcík
authors.forename: Vladimír
authors.initials: V
authors.lastname: Růicka
authors.forename: Josef
authors.initials: J
authors.lastname: Sláinský
authors.forename: Karel
authors.initials: K
authors.lastname: Masek
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006168:Guinea Pigs; D007085:Ilium / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism*; D044263:Receptors, Serotonin, 5-HT1; D044422:Receptors, Serotonin, 5-HT4; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology
chemical_list: D000276:Adjuvants, Immunologic; D011985:Receptors, Serotonin; D044263:Receptors, Serotonin, 5-HT1; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D044422:Receptors, Serotonin, 5-HT4; D012701:Serotonin; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D000109:Acetylcholine